digital health companies glp-1 weight loss London-headquartered healthcare company Voy has officially entered the Indian market through the acquisition of EarlyFit, one of India's leading online weight-loss and obesity-care platforms. The move marks a significant development in GLP-1 Telehealth Is Changing Fast

Safety concerns : Important risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, hypoglycaemia (when used with insulin or sulfonylureas), and potential worsening of diabetic retinopathy with rapid glycaemic improvement

This means there are no guaranteed standards for safety or quality

Glucose Metabolism: GH has anti-insulin effects

The thumbnail below links to a short educational video that walks through typical handling practices, such as storing the vial at appropriate temperatures, reconstituting with bacteriostatic water under a hood, and labeling aliquots with concentration and lot number